Results 11 to 20 of about 77,361 (253)

Metabolic syndrome in psychiatry: advances in understanding and management [PDF]

Advances in Psychiatric Treatment, 2014
SummaryMetabolic syndrome comprises a number of cardiovascular risk factors that increase morbidity and mortality. The increase in incidence of the syndrome among psychiatric patients has been unanimously demonstrated in recent studies and it has become one of the greatest challenges in psychiatric practice.
Ho, C.S.H., Zhang, M.W.B., Mak, A., Ho, R.C.M.   +3 more
openaire   +2 more sources

Correction to: Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence

Translational Psychiatry, 2021
A Correction to this paper has been published: https://doi.org/10.1038/s41398-021-01239 ...
Roel J. T. Mocking, Jane C. Naviaux, Kefeng Li, Lin Wang, Jonathan M. Monk, A. Taylor Bright, Caroline A. Figueroa, Aart H. Schene, Henricus G. Ruhé, Johanna Assies, Robert K. Naviaux   +10 more
doaj   +1 more source

Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence

Translational Psychiatry, 2021
Recurrent major depressive disorder (rMDD) is a relapsing-remitting disease with high morbidity and a 5-year risk of recurrence of up to 80%. This was a prospective pilot study to examine the potential diagnostic and prognostic value of targeted plasma ...
Roel J. T. Mocking, Jane C. Naviaux, Kefeng Li, Lin Wang, Jonathan M. Monk, A. Taylor Bright, Caroline A. Figueroa, Aart H. Schene, Henricus G. Ruhé, Johanna Assies, Robert K. Naviaux   +10 more
doaj   +1 more source

Untargeted metabolic analysis in dried blood spots reveals metabolic signature in 22q11.2 deletion syndrome

Translational Psychiatry, 2022
The 22q11.2 deletion syndrome (22q11.2DS) is characterized by a well-defined microdeletion and is associated with increased risk of neurodevelopmental phenotypes including autism spectrum disorders (ASD) and intellectual impairment. The typically deleted
Dorinde Korteling, Marco P. Boks, Ania M. Fiksinski, Ilja N. van Hoek, Jacob A. S. Vorstman, Nanda M. Verhoeven-Duif, Judith J. M. Jans, Janneke R. Zinkstok   +7 more
doaj   +1 more source

Immunometabolic depression: from conceptualization towards implementation

European Psychiatry, 2023
The burden on society by depression is undisputable, partly due to a chronic course pattern and depression’s large heterogeneity that contributes to non-response to standard treatments.
B. Penninx
doaj   +1 more source

Laparoscopic Banded One Anastomosis Gastric Bypass: A Single-Center Series

Journal of Obesity, 2022
Introduction. Laparoscopic one anastomosis gastric bypass (LOAGB) is a relatively new procedure for the treatment of morbid obesity and related comorbidities.
Michela Campanelli, Emanuela Bianciardi, Domenico Benavoli, Giulia Bagaglini, Giorgio Lisi, Paolo Gentileschi   +5 more
doaj   +1 more source

A retrospective evaluation of an online group ketogenic metabolic therapy intervention on mental health outcomes

Frontiers in Nutrition
BackgroundConventional treatments for depression and anxiety, including pharmacotherapy and psychotherapy, often fail to achieve long-term symptom remission and are associated with side effects, limited accessibility, and high attrition.
Erin L. Bellamy
doaj   +1 more source

From theory to practice: challenges and rewards of implementing ketogenic metabolic therapy in mental health

Frontiers in Nutrition
This perspective article delves into the implementation of Ketogenic Metabolic Therapy (KMT) by a mental health counselor who attempts to bridge the gap between emerging research and real-world clinical application.
Nicole Laurent
doaj   +1 more source

Use of Sertraline in Hemodialysis Patients

Medicina, 2021
Depression and anxiety are the most common psychiatric disorders in end-stage renal disease (ESRD) patients treated with hemodialysis (HD) and may correlate with lower quality of life and increased mortality.
Alicja Kubanek, Przemysław Paul, Mateusz Przybylak, Katarzyna Kanclerz, Jakub Jan Rojek, Marcin Renke, Leszek Bidzan, Jakub Grabowski   +7 more
doaj   +1 more source

Ketogenic metabolic therapy in the remission of chronic major depressive disorder: a retrospective case study

Frontiers in Nutrition
BackgroundThere is limited evidence describing the use of ketogenic metabolic therapy (KMT), also known as a ketogenic diet (KD), to achieve full remission of treatment-resistant major depressive disorder (MDD) in real-world clinical settings.
Nicole Laurent, Erin L. Bellamy, Donika Hristova, Ally Houston   +3 more
doaj   +1 more source